Technical Analysis for ASMB - Assembly Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Support | Bullish | 0.00% | |
| 50 DMA Support | Bullish | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.48% | |
| 20 DMA Support | Bullish | 0.48% | |
| NR7 | Range Contraction | 0.48% | |
| Inside Day | Range Contraction | -0.76% | |
| MACD Bullish Signal Line Cross | Bullish | -4.63% | |
| 180 Bullish Setup | Bullish Swing Setup | -4.63% | |
| Wide Bands | Range Expansion | -4.63% |
| Alert | Time |
|---|---|
| 50 DMA Support | about 18 hours ago |
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| 10 DMA Resistance | about 18 hours ago |
| Fell Below Previous Day's Low | about 18 hours ago |
| Down 1% | about 18 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 11/06/2024
Assembly Biosciences, Inc. Description
Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Gastroenterology Digestive System Surgery Digestive System Phenylephrine Fecal Incontinence Gastrointestinal Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.93 |
| 52 Week Low | 7.692 |
| Average Volume | 30,581 |
| 200-Day Moving Average | 14.31 |
| 50-Day Moving Average | 16.61 |
| 20-Day Moving Average | 16.86 |
| 10-Day Moving Average | 16.91 |
| Average True Range | 1.13 |
| RSI (14) | 51.22 |
| ADX | 22.74 |
| +DI | 19.27 |
| -DI | 14.91 |
| Chandelier Exit (Long, 3 ATRs) | 15.60 |
| Chandelier Exit (Short, 3 ATRs) | 17.49 |
| Upper Bollinger Bands | 18.86 |
| Lower Bollinger Band | 14.86 |
| Percent B (%b) | 0.51 |
| BandWidth | 23.70 |
| MACD Line | 0.21 |
| MACD Signal Line | 0.25 |
| MACD Histogram | -0.0399 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.15 | ||||
| Resistance 3 (R3) | 18.16 | 17.75 | 17.94 | ||
| Resistance 2 (R2) | 17.75 | 17.43 | 17.75 | 17.87 | |
| Resistance 1 (R1) | 17.32 | 17.23 | 17.12 | 17.31 | 17.80 |
| Pivot Point | 16.91 | 16.91 | 16.81 | 16.91 | 16.91 |
| Support 1 (S1) | 16.48 | 16.59 | 16.28 | 16.47 | 15.98 |
| Support 2 (S2) | 16.07 | 16.39 | 16.07 | 15.91 | |
| Support 3 (S3) | 15.64 | 16.07 | 15.84 | ||
| Support 4 (S4) | 15.63 |
